DK708488D0 - Faktor i praeparat - Google Patents

Faktor i praeparat

Info

Publication number
DK708488D0
DK708488D0 DK708488A DK708488A DK708488D0 DK 708488 D0 DK708488 D0 DK 708488D0 DK 708488 A DK708488 A DK 708488A DK 708488 A DK708488 A DK 708488A DK 708488 D0 DK708488 D0 DK 708488D0
Authority
DK
Denmark
Prior art keywords
factor
pct
protein
date
sec
Prior art date
Application number
DK708488A
Other languages
English (en)
Inventor
Karina Oestergaard Alsoee
Jesper Kihl
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK708488A priority Critical patent/DK708488D0/da
Publication of DK708488D0 publication Critical patent/DK708488D0/da
Priority to DE68913212T priority patent/DE68913212T2/de
Priority to AT90900763T priority patent/ATE101521T1/de
Priority to PCT/DK1989/000297 priority patent/WO1990006759A1/en
Priority to ES90900763T priority patent/ES2062502T3/es
Priority to JP90501447A priority patent/JPH04502324A/ja
Priority to EP90900763A priority patent/EP0449897B1/en
Priority to US08/089,905 priority patent/US5378811A/en
Priority to AU48112/90A priority patent/AU4811290A/en
Priority to DK105391A priority patent/DK105391A/da
Priority to FI912879A priority patent/FI95440C/fi
Priority to NO912387A priority patent/NO912387D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK708488A 1988-12-20 1988-12-20 Faktor i praeparat DK708488D0 (da)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
AU48112/90A AU4811290A (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
ES90900763T ES2062502T3 (es) 1988-12-20 1989-12-19 Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
AT90900763T ATE101521T1 (de) 1988-12-20 1989-12-19 Ein reines faktor i-protein und verfahren zur herstellung.
PCT/DK1989/000297 WO1990006759A1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
DE68913212T DE68913212T2 (de) 1988-12-20 1989-12-19 Ein reines faktor i-protein und verfahren zur herstellung.
JP90501447A JPH04502324A (ja) 1988-12-20 1989-12-19 純粋なｉ因子蛋白質および該蛋白質の製造方法
EP90900763A EP0449897B1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
US08/089,905 US5378811A (en) 1988-12-20 1989-12-19 Pure C3b inactivator and a process for producing said protein
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf
FI912879A FI95440C (fi) 1988-12-20 1991-06-14 Menetelmä plasmaperäisen C3b-inaktivaattoriliuoksen valmistamiseksi, joka ei sisällä oleellisesti tekijä B-aktiivisuutta eikä infektoivan viruksen aktiivisuutta
NO912387A NO912387D0 (no) 1988-12-20 1991-06-19 Rent faktor 1-protein, samt fremgangsmaate for fremstilling av proteinet.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat

Publications (1)

Publication Number Publication Date
DK708488D0 true DK708488D0 (da) 1988-12-20

Family

ID=8149208

Family Applications (2)

Application Number Title Priority Date Filing Date
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Country Status (11)

Country Link
US (1) US5378811A (da)
EP (1) EP0449897B1 (da)
JP (1) JPH04502324A (da)
AT (1) ATE101521T1 (da)
AU (1) AU4811290A (da)
DE (1) DE68913212T2 (da)
DK (2) DK708488D0 (da)
ES (1) ES2062502T3 (da)
FI (1) FI95440C (da)
NO (1) NO912387D0 (da)
WO (1) WO1990006759A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
ATE342103T1 (de) * 1998-08-25 2006-11-15 Ash Access Technology Inc Verwendung von citrat in einer kathetersperrlösung
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
DE68913212T2 (de) 1994-05-19
US5378811A (en) 1995-01-03
NO912387L (no) 1991-06-19
DK105391D0 (da) 1991-06-03
NO912387D0 (no) 1991-06-19
FI912879A0 (fi) 1991-06-14
ES2062502T3 (es) 1994-12-16
WO1990006759A1 (en) 1990-06-28
ATE101521T1 (de) 1994-03-15
EP0449897B1 (en) 1994-02-16
FI95440B (fi) 1995-10-31
AU4811290A (en) 1990-07-10
EP0449897A1 (en) 1991-10-09
FI95440C (fi) 1996-02-12
JPH04502324A (ja) 1992-04-23
DE68913212D1 (de) 1994-03-24
DK105391A (da) 1991-06-03

Similar Documents

Publication Publication Date Title
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE69323183D1 (de) Weitere indolderivate mit antiviraler wirkung
FI102293B1 (fi) Ihmisen interleukiini-3:n molekulaarinen kloonaus ja ilmentäminen
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
HU895788D0 (en) Process for producing peptides and medical products containing them
DK708488D0 (da) Faktor i praeparat
DK0528841T3 (da) Fremgangsmåde til fremstilling af pyridoxyleret hæmoglobin
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE69131253D1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
FI93843B (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DE59109261D1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ES2032812T3 (es) Vacuna.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
DE3783122D1 (de) Verwendung von rekombiniertem menschlichem alpha-interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
AU6393990A (en) Hiv related peptides
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
Heron¹ The Effect of Interferon on the Immune System: from Skepticism to Confidence?

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment